Content
Free Mental Health Assessment
Reviewed by Daniel Z. Lieberman, MD
Written by Lauren Panoff, MPH, RD
Published 07/11/2022
Updated 08/24/2024
If you’ve been diagnosed with depression, anxiety, insomnia, or chronic pain, you may have heard about a tricyclic antidepressant called doxepin.Â
However, it probably wasn’t the first antidepressant you were offered. Tricyclic antidepressants (TCAs) are effective medications, but they’re not a first-line treatment anymore. That’s because they come with a higher risk of severe side effects and interactions than newer options.Â
So when is doxepin considered the best option, and what are its potential side effects? We’re answering these questions and more.
Content
Doxepin is a prescription tricyclic antidepressant. TCAs help treat depression by blocking the reuptake of serotonin and norepinephrine, brain chemicals involved in regulating your mood, appetite, sleep, and pain perception.Â
It’s also an antagonist of your H1 and H2 histamine receptors, which play a key role in regulating your body’s sleep-wake cycle. This is why the Food and Drug Administration (FDA) approved doxepin as a treatment for adults with insomnia in 2010.
Doxepin is a commonly prescribed medication in the United States. It was first approved in 1969 and is sold as a generic medication, under various brand names, and in various forms, depending on its intended use.Â
Doxepin is commonly sold as Silenor® for insomnia and Sinequan® for depression and anxiety. A topical form is sold under the brand names Prudoxin® and Zonalon®. It’s used topically because, as we mentioned above, it blocks histamine receptors. Antihistamines help with itchy skin when applied as a cream.
Your doctor will prescribe doxepin as an oral capsule or liquid you’ll have to dilute in a beverage of your choice. Doxenpin is usually taken one to three times daily and may be taken with or without food.Â
Doxepin is used to treat conditions like:Â
Depression
Anxiety disorders
Insomnia and trouble sleeping
Chronic pain
Itching
However, doxepin is rarely used as a first-line treatment for these conditions nowadays because newer medications work just as well with fewer side effects.Â
Doxepin is an effective treatment for long-term, chronic insomnia, and short-term difficulty sleeping — which are often coexisting conditions with depression and anxiety.Â
Some studies of doxepin have shown that it’s particularly effective as a treatment for insomnia in people who frequently wake up after falling asleep. Unfortunately, it doesn’t seem to work for people who have trouble getting to sleep at the beginning of the night.
A 2013 scientific review of doxepin as an insomnia treatment looked at several studies. It concluded that doxepin, at small doses of 3 milligrams and 6 milligrams, is well tolerated, not habit-forming, and effective at managing both chronic and transient insomnia.
A 2014 review of doxepin use by older adults with difficulty sleeping also found that it was an effective treatment. Researchers noted that it “significantly reduced waking after sleep onset and increased total sleep time.”Â
Because it has strong antihistamine properties, topical doxepin (in cream form) is prescribed to treat itchiness caused by skin conditions like lichen simplex chronicus, atopic dermatitis, and chronic refractory scalp pruritus.Â
Doxepin is also occasionally used to treat long-lasting hives in adults, although it seems to have been largely phased out in favor of more effective drugs.
Doxepin is prescribed at various dosages to treat different conditions. Your healthcare provider will determine which dosage is right for you. Â
In addition, the amount of doxepin contained in each medication can vary. For instance, the dosage of doxepin used to treat major depressive disorder (150—300mg) is much higher than the typical low dose for insomnia (6—10mg).
Doxepin is generally considered a safe and effective medication, but like any prescription drug, it comes with a list of possible adverse effects. Does doxepin cause weight gain? Does it tend to make you sleepy or anxious? Let’s find out.
The most common side effects of doxepin include:
Drowsiness, sleepiness, and sedation
Constipation
Increased appetite
These side effects are only common at the high doses used to treat depression and anxiety. At the very low doses used to treat insomnia, the only side effect most patients experience is drowsiness.
The sleep-inducing effects of doxepin last several hours after you take the medication. Although doxepin doesn’t usually cause next-day tiredness, it might make you drowsy if you only sleep for a short time. Â
To avoid daytime drowsiness, only use doxepin to treat insomnia if you plan to sleep for seven to eight hours immediately after taking the medication.Â
In rare cases, doxepin can cause serious side effects, like:
Blurred vision and eye pain
Anxiety
Suicidal thoughts
Mania and behavioral changes
Dry mouth
Drops in blood pressure
Cardiovascular issues, including changes to heart rate or heart rhythm
Urinary retention
Weight gain
Changes to blood sugar levels
In extreme cases, doxepin can cause trouble breathing or an allergic reaction. If you think you’re experiencing any of these severe side effects, seek immediate medical advice.
What if you forget to take a dose? If you miss a dose, take it as soon as possible unless it’s almost time for your next dose. If that’s the case, don’t double-dose — just take your regular dose. Of course, if you’re using it for sleep and forget to take it, you’ll want to wait until the next night.
It’s possible to overdose on doxepin, but unlikely given that the dosage of doxepin prescribed to treat insomnia is less than five percent of the maximum recommended dosage for this medication. Still, signs of doxepin overdose include:Â
Trouble concentrating
Vomiting
Fever or cold body temperature
Hallucination
Increased pupil size
Irregular heartbeat
Stiffening of muscles
Coma
If you’re concerned you or someone you’re with has taken an unsafe amount of doxepin, call your local emergency number or the national toll-free Poison Control hotline at 1-800-222-1222 ASAP.
There are over 600 known drugs that don’t mix well with doxepin to varying degrees. Many of these interactions can be managed safely, so the presence of an interaction doesn’t always mean the drug is off limits. In some cases though, the interactions can be dangerous.
You should generally not use doxepin alongside other antidepressants, particularly ones that affect serotonin, like fluoxetine, duloxetine, citalopram, paroxetine, and fluvoxamine, as well as monoamine oxidase inhibitors (MAOIs) like selegiline, phenelzine, and tranylcypromine.Â
Tell your provider if you’ve used an MAOI within the last two weeks, and disclose all other medications you currently take before starting doxepin.
Other drugs that can interact with doxepin include:
Cimetidine, an over-the-counter H2 blocker for acid reflux and indigestion
Sertraline, a selective serotonin reuptake inhibitor (SSRI) antidepressant
Quinidine, a medication used to treat certain types of irregular heartbeats
Sleeping pills
Narcotic pain medications
Anxiety medications
Anti-seizure medicationsÂ
Over-the-counter sleep aids
Don’t drink alcohol when you’re taking doxepin, as this combo can cause drowsiness and trouble concentrating, increasing your risk of having an accident.Â
Tell your provider if you’re breastfeeding, as doxepin can transfer through breast milk. There are cases of it being harmful to nursing infants, and there’s not enough data to provide confidence in its safety in this scenario.Â
Finally, doxepin is not recommended for individuals who have the following conditions because it can make them worse:Â
Glaucoma
Sleep apnea
Heart conditions
Bipolar disorder
Breathing problems
Urinary retention (trouble emptying your bladder)
Liver disease
Doxepin needs to be taken right on schedule. As an antidepressant, this typically means taking it once daily at bedtime or divided up into two or three smaller doses taken throughout the day. When it’s used for depression, it usually takes about two weeks to start to feel the beneficial effects and four weeks for the full effect.
For insomnia, it works pretty much right away. You should take doxepin at least three hours after consuming a meal and within 30 minutes of going to bed. After taking doxepin, limit your activities to those necessary to prepare to go to sleep.Â
Doxepin has a half-life of 15 hours, meaning each dose of the medication will be halfway eliminated from your body after roughly 15 hours. A 6mg dose of doxepin will reach its peak concentration in approximately three and a half hours.Â
Doxepin may or may not be your secret to improved mental health or better sleep. You and your healthcare provider will need to make that decision together. We’re just here to give you some information to make that choice effectively.Â
Considering a switch to doxepin? Here’s what to keep in mind:
It’s effective but comes with risks. Doxepin is an effective Tricyclic Antidepressant (TCA) for depression, insomnia, anxiety, and chronic pain. However, like other Tricyclic Antidepressants (TCAs), it has a long list of potentially serious side effects. Be sure to understand these — including possible drug interactions — before taking it.Â
It’s important to take it as directed. If you miss a dose of doxepin and it’s almost time for your next one, don’t double the dose. Just take your next regularly scheduled dose. Don’t take doxepin with alcohol, and be aware of its potential drug interactions.Â
There are alternatives. While doxepin may be the right treatment for you, we recommend discussing alternative treatments with your healthcare provider if you notice side effects. There are many other medications available that you might tolerate better.
Your mental health matters, and we can help. If you think you need antidepressants or other resources, consider online therapy and check out our full antidepressant list for more information.
Dr. Daniel Z. Lieberman is the senior vice president of mental health at Hims & Hers and of psychiatry and behavioral sciences at George Washington University. Prior to joining Hims & Hers, Dr. Lieberman spent over 25 years as a full time academic, receiving multiple awards for teaching and research. While at George Washington, he served as the chairman of the university’s Institutional Review Board and the vice chair of the Department of Psychiatry and Behavioral Sciences.
Dr. Lieberman’s has focused on , , , and to increase access to scientifically-proven treatments. He served as the principal investigator at George Washington University for dozens of FDA trials of new medications and developed online programs to help people with , , and . In recognition of his contributions to the field of psychiatry, in 2015, Dr. Lieberman was designated a distinguished fellow of the American Psychiatric Association. He is board certified in psychiatry and addiction psychiatry by the American Board of Psychiatry and Neurology.
As an expert in mental health, Dr. Lieberman has provided insight on psychiatric topics for the U.S. Department of Health and Human Services, U.S. Department of Commerce, and Office of Drug & Alcohol Policy.
Dr. Lieberman studied the Great Books at St. John’s College and attended medical school at New York University, where he also completed his psychiatry residency. He is the coauthor of the international bestseller , which has been translated into more than 20 languages and was selected as one of the “Must-Read Brain Books of 2018” by Forbes. He is also the author of . He has been on and to discuss the role of the in human behavior, , and .
1992: M.D., New York University School of Medicine
1985: B.A., St. John’s College, Annapolis, Maryland
2022–Present: Clinical Professor, George Washington University Department of Psychiatry and Behavioral Sciences
2013–2022: Vice Chair for Clinical Affairs, George Washington University Department of Psychiatry and Behavioral Sciences
2010–2022: Professor, George Washington University Department of Psychiatry and Behavioral Sciences
2008–2017: Chairman, George Washington University Institutional Review Board
2022: Distinguished Life Fellow, American Psychiatric Association
2008–2020: Washingtonian Top Doctor award
2005: Caron Foundation Research Award
Lieberman, D. Z., Cioletti, A., Massey, S. H., Collantes, R. S., & Moore, B. B. (2014). Treatment preferences among problem drinkers in primary care. International journal of psychiatry in medicine, 47(3), 231–240. https://journals.sagepub.com/doi/10.2190/PM.47.3.d?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
Lieberman, D. Z., Swayze, S., & Goodwin, F. K. (2011). An automated Internet application to help patients with bipolar disorder track social rhythm stabilization. Psychiatric services (Washington, D.C.), 62(11), 1267–1269. https://ps.psychiatryonline.org/doi/10.1176/ps.62.11.pss6211_1267?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
Lieberman, D. Z., Massey, S. H., & Goodwin, F. K. (2010). The role of gender in single vs married individuals with bipolar disorder. Comprehensive psychiatry, 51(4), 380–385. https://www.sciencedirect.com/science/article/abs/pii/S0010440X0900128X?via%3Dihub
Lieberman, D. Z., Kolodner, G., Massey, S. H., & Williams, K. P. (2009). Antidepressant-induced mania with concomitant mood stabilizer in patients with comorbid substance abuse and bipolar disorder. Journal of addictive diseases, 28(4), 348–355. https://pubmed.ncbi.nlm.nih.gov/20155604
Lieberman, D. Z., Montgomery, S. A., Tourian, K. A., Brisard, C., Rosas, G., Padmanabhan, K., Germain, J. M., & Pitrosky, B. (2008). A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder. International clinical psychopharmacology, 23(4), 188–197. https://journals.lww.com/intclinpsychopharm/abstract/2008/07000/a_pooled_analysis_of_two_placebo_controlled_trials.2.aspx
Hims & Hers has strict sourcing guidelines to ensure our content is accurate and current. We rely on peer-reviewed studies, academic research institutions, and medical associations. We strive to use primary sources and refrain from using tertiary references. See a mistake? Let us know at [email protected]!